Stockhub

Citius Pharmaceuticals, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

1 September 2022

  • curprev 04:1504:15, 1 September 2022 >Nick 1,196 bytes +1,196 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by s..."
Retrieved from "https://stockhub.co/research/Citius_Pharmaceuticals,_Inc."